 Cyclacel Pharmaceuticals Inc NASDAQ: CYCC priced an underwritten public offering of 1.81 million common shares at 7 per share, a discount of 11 on the last close price of 7.87 on Thursday. It will raise gross proceeds of approximately 12.65 million. 